Specifications: Form: Lyophilised powder Unit Size: 50 mg Appearance: Blue to blue-green solid Storage (unreconstituted): -20 C, dark, dry Reconstitution: Sterile water for injection Stability (reconstituted): Store at 28 C, short-term Usage Notice: For research use only
Cardiovasc Res 92(1):1018 Moris D, Spartalis M, Spartalis E, Karachaliou GS, Karaolanis GI, Tsourouflis G et al (2017) The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox
Test characteristics Species Human Sample types Serum and EDTA plasma Sample volume 25 L Assay range 0.9 - 940 pmol/L (2.8 - 2940 pg/mL) Detection limit 0.65 pmol/L Incubation 2h + 15 min Detection method Chemiluminescence specificity The following cross-reactions have been tested: GLP-1 (1-36) amide 88% GLP-1 (7-36) amide 93% GLP-1 (9-36) amide 100% GLP-1 (1-37) Not detected GLP-1 (7-37) Not detected Glucagon Not detected GIP Not detected GLP-2 Not detected Oxyntomodulin Not detected Glicentin Not detected Miniglucagon Not detected MPGF Not detected Liraglutide Not detected Exenatide Not detected Lixisenatide Not detected Dulaglutide 0.07% directions for use Certificate of Analysis directions for use Certificate of Analysis SAFETY DATA SHEET technical notes For technical notes specific to Mercodia Total GLP-1 ELISA see: TN34-0154 Sample collection and handling for Mercodia Total GLP-1 ELISA (10-1278-01) references Stinson, S
That development raises an important societal and clinical question: What happens when weight-loss pharmacotherapy becomes more powerful than our frameworks for defining health
Plasma samples from 136 participants with MDD enrolled into the Mayo Pharmacogenomics Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) were profiled at baseline and after 8 weeks of treatment
